These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 3259165

  • 1. Radiosensitivity of NK lytic activities and NK-mediated hematopoietic colony inhibition: effect of activation with IL-2 and blocking of the T-200 molecule.
    Keever CA, Benazzi E, Kernan NA, Welte K, O'Reilly RJ, Bordignon C.
    Cell Immunol; 1988 Apr 15; 113(1):143-57. PubMed ID: 3259165
    [Abstract] [Full Text] [Related]

  • 2. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
    Vose BM, Bonnard GD.
    J Immunol; 1983 Feb 15; 130(2):687-93. PubMed ID: 6600251
    [Abstract] [Full Text] [Related]

  • 3. K562 killing by K, IL 2-responsive NK, and T cells involves different effector cell post-binding trigger mechanisms.
    Shanahan F, Brogan MD, Newman W, Targan SR.
    J Immunol; 1986 Jul 15; 137(2):723-6. PubMed ID: 3487579
    [Abstract] [Full Text] [Related]

  • 4. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA, Pekle K, Gazzola MV, Collins NH, Bourhis JH, Gillio A.
    J Immunol; 1989 Nov 15; 143(10):3241-9. PubMed ID: 2809200
    [Abstract] [Full Text] [Related]

  • 5. Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon.
    Degliantoni G, Murphy M, Kobayashi M, Francis MK, Perussia B, Trinchieri G.
    J Exp Med; 1985 Nov 01; 162(5):1512-30. PubMed ID: 3932579
    [Abstract] [Full Text] [Related]

  • 6. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
    Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA.
    J Exp Med; 1982 Jun 01; 155(6):1823-41. PubMed ID: 6176669
    [Abstract] [Full Text] [Related]

  • 7. Target cell-directed inactivation and IL-2-dependent reactivation of LAK cells.
    Xiao J, Brahmi Z.
    Cell Immunol; 1989 Sep 01; 122(2):295-306. PubMed ID: 2788512
    [Abstract] [Full Text] [Related]

  • 8. Interferon-gamma-treated K562 target cells distinguish functional NK cells from lymphokine-activated killer (LAK) cells.
    Powell J, Stone J, Chan WC, Yang ZD, Leatherbury A, Sell KW, Wiktor-Jedrzejczak W, Ahmed-Ansari A.
    Cell Immunol; 1989 Feb 01; 118(2):250-64. PubMed ID: 2491960
    [Abstract] [Full Text] [Related]

  • 9. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
    Burns GF, Triglia T, Werkmeister JA.
    J Immunol; 1984 Sep 01; 133(3):1656-63. PubMed ID: 6611374
    [Abstract] [Full Text] [Related]

  • 10. IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.
    Peace DJ, Kern DE, Schultz KR, Greenberg PD, Cheever MA.
    J Immunol; 1988 May 15; 140(10):3679-85. PubMed ID: 2896213
    [Abstract] [Full Text] [Related]

  • 11. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
    van de Griend RJ, Tax WJ, van Krimpen BA, Vreugdenhil RJ, Ronteltap CP, Bolhuis RL.
    J Immunol; 1987 Mar 01; 138(5):1627-33. PubMed ID: 2949018
    [Abstract] [Full Text] [Related]

  • 12. NK and LAK activities from human marrow progenitors. I. The effects of interleukin-2 and interleukin-1.
    Keever CA, Pekle K, Gazzola MV, Collins NH, Gillio A.
    Cell Immunol; 1990 Mar 01; 126(1):211-26. PubMed ID: 1689220
    [Abstract] [Full Text] [Related]

  • 13. The functional loss of human natural killer cell activity induced by K562 is reversible via an interleukin-2-dependent mechanism.
    Abrams SI, Brahmi Z.
    Cell Immunol; 1986 Sep 01; 101(2):558-70. PubMed ID: 3489541
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B, Lebow LT, Bradley TP.
    J Immunol; 1984 Feb 01; 132(2):594-8. PubMed ID: 6606675
    [Abstract] [Full Text] [Related]

  • 15. Resting human peripheral blood lymphocytes can be activated to cytolytic function by antibodies to CD3 in the absence of exogenous interleukin-2.
    Scott CF, Lambert JM, Bolender S, Blattler WA.
    Cell Immunol; 1988 Jul 01; 114(2):370-84. PubMed ID: 3260543
    [Abstract] [Full Text] [Related]

  • 16. Natural killer cells in rhesus monkeys: properties of effector cells which lyse Raji targets.
    Carver FM, Thomas JM.
    Cell Immunol; 1988 Nov 01; 117(1):56-69. PubMed ID: 2902933
    [Abstract] [Full Text] [Related]

  • 17. Lysis of pig endothelium by IL-2 activated human natural killer cells is inhibited by swine and human major histocompatibility complex (MHC) class I gene products.
    Itescu S, Artrip JH, Kwiatkowski PA, Wang SF, Minanov OP, Morgenthau AS, Michler RE.
    Ann Transplant; 1997 Nov 01; 2(1):14-20. PubMed ID: 9869836
    [Abstract] [Full Text] [Related]

  • 18. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.
    Grimm EA, Ramsey KM, Mazumder A, Wilson DJ, Djeu JY, Rosenberg SA.
    J Exp Med; 1983 Mar 01; 157(3):884-97. PubMed ID: 6601174
    [Abstract] [Full Text] [Related]

  • 19. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
    Vujanovic NL, Herberman RB, Olszowy MW, Cramer DV, Salup RR, Reynolds CW, Hiserodt JC.
    Cancer Res; 1988 Feb 15; 48(4):884-90. PubMed ID: 3257412
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of bone marrow colony formation by human natural killer cells and by natural killer cell-derived colony-inhibiting activity.
    Degliantoni G, Perussia B, Mangoni L, Trinchieri G.
    J Exp Med; 1985 May 01; 161(5):1152-68. PubMed ID: 3838767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.